Glucosamine Celadrin MSM by Bluebonnet — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

4 Capsule(s) Serving Size

30 Servings

Other Combinations Product Type

33% Evidence Coverage

Supplement Facts — Evidence Check

Glucosamine Sulfate

1200 mg

📊 Market median: 1000.0mg (1115 products) 📚 22 studies (Tier A: 0, B: 9)

This product: 1200mg

Celadrin Fatty Acid Complex

1200 mg

MSM

400 mg

📊 Market median: 1000.0mg (2 products)

This product: 400mg

Other Ingredients

Kosher Vegetable Capsules Vegetable Magnesium Stearate

Label Claims — Verification

❓ Nutrient

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (89% of products) Nutrient (16% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free Sugar Free

Product Information

📋 Directions for Use

Directions: As a dietary supplement, take four capsules daily or as directed by a healthcare practitioner.

⚠️ Warnings & Precautions

Contains: Crustacean shellfish (crab, lobster, shrimp)

🧪 Formulation Notes

Bluebonnet’s Glucosamine Celadrin MSM Capsules are specially formulated with a combination of pure glucosamine sulfate, Celadrin and OptiMSM, an active form of sulfur. Celadrin, a blend of esterified fatty acids, promotes flexibility and joint health.

Made with non GMO ingredients

PureFlex

Contains: Crustacean shellfish (crab, lobster, shrimp)

Free of milk, egg, fish, tree nuts, peanuts, wheat and soybeans. Also free of corn, yeast, gluten, barley, rice and sugar.

Additional Information

Available in easy-to-swallow vegetable capsules for maximum assimilation and absorption

1123C

Made with non GMO ingredients

Gluten free

Product Details

UPC / SKU 7 43715 01123 6

DSLD Entry Date 2018-07-25

Product Type Other Combinations

Form Capsule

Brand Bluebonnet

DSLD ID 179208

Data Updated 2026-04-11

Research Evidence

39 Research Sources

50 Avg Quality Score

20 Rct

9 Meta Analysis

4 Clinical Trial

3 Systematic Review

1 Regulatory Source

1 Openfda Safety

B Interventions for the management of temporomandibular joint osteoarthritis

Systematic Review The Cochrane database of systematic reviews 2012

PubMed DOI Cochrane

B Glucosamine therapy for treating osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2005

PubMed Cochrane

B Chondroitin for osteoarthritis

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Efficacy and safety of the combination of glucosamine and chondroitin for knee osteoarthritis: a systematic review and meta-analysis

Meta Analysis Archives of orthopaedic and trauma surgery 2023

PubMed DOI

B Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

Rct The New England journal of medicine 2006

PubMed

B Oral Glucosamine in the Treatment of Temporomandibular Joint Osteoarthritis: A Systematic Review

Systematic Review International journal of molecular sciences 2023

PubMed DOI

B Scientific Opinion on glucosamine and joint health

Regulatory Source EFSA Journal 2009

DOI

B Clinical Efficacy and Safety of Chondroitin Combined with Glucosamine in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis

Meta Analysis Computational and mathematical methods in medicine 2022

PubMed DOI

B Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

Rct Annals of the rheumatic diseases 2016

PubMed DOI

B Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials

Meta Analysis Journal of orthopaedic surgery and research 2018

PubMed DOI

View all evidence for Glucosamine →